A history of concussion is linked to a significantly higher risk of long-term disability after an MVA, underscoring the need ...
Oxeia Biopharmaceuticals plans to enroll 160 patients in a Phase 2b clinical trial of OXE103, therapy for persistent ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results